Publications
5808 Results
- Journal / Conference
- Journal of Thoracic Oncology 2(5):440-444
- Year
- 2007
- Research Committee(s)
- Lung
- Study Number(s)
- S9718
Phase II Study of Gemcitabine and Cisplatin in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group Study 9718 [PMID: 17473660]
- Journal / Conference
- Archives of Otolaryngology-Head & Neck Surgery 133(10):1044-1050
- Year
- 2007
- Research Committee(s)
- Head and Neck
- Study Number(s)
- S9709
Tansoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group phase 2 trial S9709 [PMID17938330]
- Journal / Conference
- Cancer Genetics and Cytogenetics 176:22-27
- Year
- 2007
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9809
Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study [PMID17574960]
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#11051
- Year
- 2007
- Research Committee(s)
- Breast
- Study Number(s)
- S0012
Screening for clonal hematopoiesis as a predictive marker for development of t-AML following adjuvant therapy for breast cancer (S0012)
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#7513
- Year
- 2007
- Research Committee(s)
- Lung
- Study Number(s)
- S0023
Updated analysis of SWOG 0023: a randomized phase III trial of gefitinib versus placebo maintenance after definitive chemoradiation followed by docetaxel in patients with locally advanced stage III non-small cell lung cancer
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#7524
- Year
- 2007
- Research Committee(s)
- Lung
- Study Number(s)
- S0124
Cisplatin (Cis)/etoposide (VP16) compared to cis/irinotecan (CPT11) in extensive-stage small cell lung cancer (E-SCLC): pharmacogenomic (PG) and comparative toxicity analysis of JCOG 9511 and SWOG 0124
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#5551
- Year
- 2007
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0200
Phase III randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy: Southwest Oncology Group Protocol S0200
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#LBA4509
- Year
- 2007
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0205
Phase III study of gemcitabine (G) plus cetuximab (C) versus gemcitabine in patients (pts) with locally advanced or metastatic pancreatic adenocarcinoma (PC): SWOG S0205 study
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#6014
- Year
- 2007
- Research Committee(s)
- Head and Neck
- Study Number(s)
- S0216
S0216: a Southwest Oncology Group (SWOG) phase II trial of docetaxel (T), cisplatin (P), and fluorouracil (F) induction followed by accelerated fractionation/concomitant boost (AF/CB) radiotherapy (RT) and concurrent cisplatin for advanced head and neck squamous cell cancer (HNSCC)
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#15562
- Year
- 2007
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0312